AlbadaJNieuwenhuisHKSixmaJJ. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Circulation1989;80:935–40.
2.
KleinSMD'ErcoleFGreengrassRAWarnerDS. Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumbar plexus block. Anesthesiology1997;87:1576–9.
3.
MontoyaJPPokalaNMeldeSL. Retroperitoneal hematoma and enoxaparin. Ann Intern Med1999;131:796–7.
4.
VerstraeteM. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs1990;40:498–530.
5.
FreedmanMD. Pharmacodynamics, clinical indications, and adverse effects of heparin. J Clin Pharmacol1992;32:584–96.
6.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
7.
WeitzJI. Low-molecular-weight heparins. N Engl J Med1997;337:688–98.
8.
ZedPJTisdaleJEBorzakS. Low-molecular-weight heparins in the management of acute coronary syndromes. Arch Intern Med1999;159: 1849–57.
